Precision Engineering of the Genome, Epigenome and Transcriptome - VIRTUAL CONTENT AVAILABLE ON DEMAND
joint with Plant Genome Engineering: From Lab to Field - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Charles Gersbach, Rachel E. Haurwitz and Fyodor D. Urnov Date: March 08 - 10, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
For important information on the coronavirus, please click here
Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposia conference will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering. The conference will also highlight recent advances in developing human therapeutics with these tools, including emerging clinical trial results and preclinical examples of novel modes of intervention. The conference will include a variety of topics of interest to the broad research community, including next-generation applications such as high-throughput screening, synthetic biology, and chromatin and RNA imaging and diagnostics. Finally, the conference will conclude with examples of how emerging technologies can be integrated for an unprecedented level of resolution of cellular processes, such as genome engineering combined with single-cell analysis methods. Collectively, this meeting will build on its history of success by familiarizing the audience with the latest advances in tool development, providing an update on clinical application of these tools, and generating an appreciation for the breadth of scientific areas impacted by the Genome Engineering Revolution.
Scholarship Deadline: February 22 2021
Abstract Deadline: February 9 2021
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge the generous grant for this conference provided by:National Center for Advancing Translational Sciences (NCATS)
Grant No. 1R13TR003731-01
Funding for this conference was made possible (in part) by 1R13TR003731-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.